UTime to acquire Bowen Therapeutics to enhance monkeypox vaccine development
UTime Limited (NASDAQ: WTO), a prominent player in the healthcare sector, has officially signed a non-disclosure agreement (NDA) to acquire Bowen Therapeutics Inc, including its laboratory at UMASS Medical School. This significant development underscores UTime’s commitment to expanding its presence in the global vaccine market and advancing the registration of an innovative monkeypox vaccine with […]